NCT06777134 Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients
| NCT ID | NCT06777134 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Berivan Beril Kılıç |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 73 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 73 participants in total. It began in 2025-01-01 with a primary completion date of 2026-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
we aim to investigate the relationship between pelvic floor dysfunctions, core endurance, hip external rotation muscle strength, and tibialis posterior and tibialis anterior muscle activation in patients diagnosed with MS
Eligibility Criteria
Inclusion Criteria: * EDSS score between 0 and 4.0 * Having access to the internet via a high-speed smartphone or computer * Scoring at least 21 points on the MoCA * Having a score of Stage 3 or higher on the Functional Ambulation Scale. Exclusion Criteria: * Having hearing or vision problems. * Participating in any exercise program. * Having accompanying other neurological, cardiovascular, or orthopedic disorders. * A history of an MS relapse or medication change within the last 6 months. * Being in a physical condition that prevents participation in exercises. * Comorbid conditions that negatively affect oxygen transport (e.g., severe anemia, peripheral artery disease, etc.)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06777134 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06777134 currently recruiting?
Yes, NCT06777134 is actively recruiting participants. Contact the research team at fztbkilic@gmail.com for enrollment information.
Where is the NCT06777134 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06777134 clinical trial?
NCT06777134 is sponsored by Berivan Beril Kılıç. The trial plans to enroll 73 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.